## Melan -A/MART-1 is a melanoma differentiation antigen that is recognized by a high proportion of cytolytic T lymphocyte (CTL) clones derived from human leukocyte antigen (HLA)-A2 Ο© melanoma patients. Whereas peptide Melan-A/ MART-1 27-35 was originally defined as the immunodominant CTL epitope,
Clinical significance of MART-1 and HLA-A2 expression and CD8+ T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients
β Scribed by Kageshita, Toshiro; Kawakami, Yutaka; Ono, Tomomichi
- Book ID
- 119560766
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 414 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0923-1811
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
From the peripheral blood lymphocytes (PBLs) of melanoma patient SK29(AV) we have previously isolated 2 independent cytolytic T lymphocyte (CTL) clones (CTL7/147 and CTL13/211), which lysed autologous tumor cells in association with HLA-B45.1. As demonstrated here, both CTL clones were directed agai
Peptide specificity of cultured tumor-infiltrating lymphocytes (TIL) was systematically investigated in a group of HLA-A2. I + metastatic melanoma patients consecutively referred to our department for surgical treatment. Seven samples from 6 patients were studied. All surgical specimens showed evide